ASTROTECH Corp Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
ASTROTECH Corp (ASTC) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $4.84 per share for the 9-month period ending 2026-03-31, per its 10-Q/A filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-06
- ASTROTECH Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-09-30 was $4.73, a 57.39% decline year-over-year.
- ASTROTECH Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-09-30 was $11.10, a 9.25% increase year-over-year.
- ASTROTECH Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-09-30 was $10.16, a 2209.09% increase year-over-year.
- ASTROTECH Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-09-30 was $0.44.
- ASTROTECH Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $9.43, a 5.79% decline from fiscal 2024.
- ASTROTECH Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $10.01, a 19.73% decline from fiscal 2023.
- ASTROTECH Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $12.47, a 35.05% decline from fiscal 2022.
- ASTROTECH Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $19.20, a 284.00% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $4.84 10-Q/A · filed 2026-08-06 | ||||
| 2025-12-31 | $4.73 10-Q · filed 2026-02-13 | ||||
| 2025-09-30 | $4.73 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | $9.43 10-K · filed 2025-09-26 | ||||
| 2025-03-31 | $10.07 10-Q · filed 2025-05-14 | ||||
| 2024-12-31 | $10.81 10-Q · filed 2025-02-14 | ||||
| 2024-09-30 | $11.10 10-Q · filed 2024-11-13 | ||||
| 2024-06-30 | $10.01 10-K · filed 2025-09-26 | ||||
| 2024-03-31 | $10.12 10-Q · filed 2024-05-14 | ||||
| 2023-12-31 | $10.16 10-Q · filed 2024-02-13 | ||||
| 2023-09-30 | $10.16 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | $12.47 10-K · filed 2024-09-20 | ||||
| 2023-03-31 | $13.20 10-Q · filed 2023-05-12 | ||||
| 2022-12-31 | $13.20 10-Q · filed 2023-02-13 | ||||
| 2022-09-30 | $0.44 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | $19.20 10-K · filed 2023-09-28 | $0.64 10-K · filed 2022-09-15 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | ||||
| 2021-06-30 | $5.00 10-K · filed 2022-09-15 | ||||
| 2021-03-31 | $5.00 10-Q · filed 2021-05-14 | ||||
| 2020-12-31 | $0.00 10-Q · filed 2021-02-16 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-13 | ||||
| 2020-06-30 | $1.85 10-K · filed 2021-09-21 | ||||
| 2020-03-31 | $1.85 10-Q · filed 2020-05-14 | ||||
| 2019-12-31 | $1.85 10-Q · filed 2020-02-14 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 | ||||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-13 | ||||
| 2018-12-31 | $0.00 10-Q · filed 2019-02-12 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-14 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 | ||||
| 2017-12-31 | $0.00 10-Q · filed 2018-02-12 | ||||
| 2017-09-30 | $0.00 10-Q/A · filed 2018-02-12 | ||||
| 2017-06-30 | $6.15 10-K · filed 2018-09-25 | $1.23 10-K · filed 2017-09-18 | |||
| 2017-03-31 | $1.67 10-Q · filed 2017-05-09 | ||||
| 2016-12-31 | $1.67 10-Q · filed 2017-02-13 | ||||
| 2016-09-30 | $1.67 10-Q · filed 2016-11-14 | ||||
| 2016-06-30 | $1.50 10-K · filed 2017-09-18 | ||||
| 2016-03-31 | $1.50 10-Q · filed 2016-05-11 | ||||
| 2015-12-31 | $0.00 10-Q · filed 2016-02-10 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-12 | ||||
| 2015-06-30 | $2.76 10-K · filed 2016-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |